Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Approvable letter for Entereg in postoperative ileus

Nov. 7, 2006

Positive preclinical results for SCY-635, a novel Scynexis anti-HCV candidate

Nov. 7, 2006

Satavaptan reduces paracenteses in cirrhotic patients with ascites

Nov. 7, 2006

Phase I CpG-10101 results show benefit in HCV patients with relapse after response

Nov. 6, 2006

PRECiSE 2 analyses, other new data on certolizumab presented

Nov. 6, 2006

HepDirect prodrug of prolyl 4-hydroxylase inhibitor may be useful in liver fibrosis

Nov. 3, 2006

Avecia and Illumigen sign development and manufacturing agreement for IB-657

Nov. 3, 2006

Maintenance of remission assessed with teduglutide in Crohn's disease patients

Nov. 3, 2006

Further phase II results show efficacy of XP-19986 in GERD

Nov. 3, 2006

GI-5005 safe in ongoing phase Ib study in hepatitis C infection

Nov. 3, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...